PD-1 Regulates the Growth of Human Mastocytosis Cells

[ABSTRACT] Background: Programmed death-1 (PD-1) is a marker for human neoplastic T cells. Here, we evaluated whether or not PD-1 was also a marker for human mastocytosis, and explored the role of PD-1 in human mastocytosis cells. Methods: Immunohistochemical analysis was used to evaluate the expres...

Full description

Saved in:
Bibliographic Details
Published inAllergology International Vol. 62; no. 1; pp. 99 - 104
Main Authors Kataoka, Tatsuki R, Fujimoto, Masakazu, Moriyoshi, Koki, Koyanagi, Itsuko, Ueshima, Chiyuki, Kono, Fumihiko, Tsuruyama, Tatsuaki, Okayama, Yoshimichi, Ra, Chisei, Haga, Hironori
Format Journal Article
LanguageJapanese
English
Published England JAPANESE SOCIETY OF ALLERGOLOGY 2013
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[ABSTRACT] Background: Programmed death-1 (PD-1) is a marker for human neoplastic T cells. Here, we evaluated whether or not PD-1 was also a marker for human mastocytosis, and explored the role of PD-1 in human mastocytosis cells. Methods: Immunohistochemical analysis was used to evaluate the expression of PD-1 in clinical samples of human cutaneous mastocytosis. The expression of PD-1 in human mastocytosis cell lines was checked by RTPCR, western blotting and flow cytometry. We stimulated human mastocytosis cell lines (LAD2 and HMC1.2) with recombinant ligand for PD-1, PD-L1 (rPD-L1), and tested the proliferative activity and the status of signal molecules by Cell Counting Kit-8 and ELISA, respectively. Results: Ten of 30 human cutaneous mastocytosis cases (33.3%) expressed PD-1 protein. We also found that a human mastocytosis line LAD2 cells expressed PD-1 protein on their surfaces. The administration with rPD-L1 suppressed the stem cell factor-dependent growth of the LAD2 cells. And, rPD-L1 activated SHP-1 and SHP-2 simultaneously, and decreased the phosphorylation of AKT, in LAD2 cells. In contrast, we could not detect the expression of PD-1, and the significant effect of rPD-L1 on the mutated KIT-driven growth of HMC1.2 cells. Conclusions: PD-1 could be a marker for human cutaneous mastocytosis and regulate the growth of human PD-1-positive mastocytosis cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1323-8930
1440-1592
DOI:10.2332/allergolint.12-oa-0450